Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells

<div>Immunohistochemical analysis of Nanog in PDAC (pancreatic duct adenocarcinoma) tissues. In PDAC tissues, immunoreactivity for Nanog was observed in the nucleus or nucleoplasm of cancer cells (a–c), with no immunoreactivity in the surrounding stroma (d). The immunoreactivity was different in the respective cases: (a) strong; (b) moderate; (c) weak; and (d) absent expression (scale bar, 100 <i>μ</i>m).</div>

Evidence-Based Complementary and Alternative Medicine

fig1

Figure 1

Figure 1: Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells 